MALAT1 and colorectal carcinoma: Serum MALAT1 and PVT1 also discriminated CRC patients from AP with an AUC = 0.823, 95% CI = 0.7210 to 0.9255, p = 0.0004, with sensitivity of 74%, specificity of 92% at a cutoff > 55.6-fold and AUC = 0.769, 95% CI = 0.6581 to 0.8795, p = 0.0010, with sensitivity of 60%, specificity of 94% at a cutoff > 73.9-fold, respectively.